Evaluation of serum sialic acid fractions as markers for malignant melanoma
- 1 April 1994
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 78 (1-3) , 171-175
- https://doi.org/10.1016/0304-3835(94)90047-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Ganglioside profiles of experimental melanomas and of their melanosomal fractionsMelanoma Research, 1995
- Levels of Disialogangliosides in Sera of Melanoma Patients Monitored by Sensitive ThinLayer Chromatography and ImmunostainingJNCI Journal of the National Cancer Institute, 1989
- Role of the Clinical Laboratory in the Diagnosis and Management of Malignant MelanomaMayo Clinic Proceedings, 1989
- Release of an Mr 140,000 glycoprotein in the culture media of certain human sarcoma and melanoma cell linesEuropean Journal of Cancer and Clinical Oncology, 1985
- Review of melanoma antigens recognized by monoclonal antibodies (MAbs). their functional significance and applications in diagnosis and treatment of melanomaPathology, 1985
- Prediction of malignant melanoma recurrence by serumN‐acetylneuraminic acidInternational Journal of Cancer, 1983
- Total and lipid-bound sialic acid levels in sera from patients with cancerClinica Chimica Acta; International Journal of Clinical Chemistry, 1982
- Serum sialic acid concentrations in malignant melanomaEuropean Journal of Cancer and Clinical Oncology, 1981
- Alteration of gangliosides in plasma and red cells of humans bearing melanoma tumorsBiochemical and Biophysical Research Communications, 1978